Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Terazosin hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely terazosin 1 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely terazosin 10 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely terazosin 5 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely terazosin 2 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely terazosin 1 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
|
Terazosin hydrochloride 10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
|
Terazosin hydrochloride 5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
|
Terazosin hydrochloride 2mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
|
Terazosin (as terazosin hydrochloride) 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
|
Terazosin (as terazosin hydrochloride) 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
|
Terazosin (as terazosin hydrochloride) 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
|
Terazosin (as terazosin hydrochloride) 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
1 |
Terazosin (as terazosin hydrochloride) 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
1 |
Terazosin (as terazosin hydrochloride) 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Terazosin hydrochloride |
Inferred relationship |
Some |
1 |
Terazosin (as terazosin hydrochloride) 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terazosin hydrochloride |
Inferred relationship |
Some |
1 |
Terazosin (as terazosin hydrochloride) 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terazosin hydrochloride |
Inferred relationship |
Some |
1 |
Terazosin (as terazosin hydrochloride) 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terazosin hydrochloride |
Inferred relationship |
Some |
1 |
Terazosin (as terazosin hydrochloride) 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terazosin hydrochloride |
Inferred relationship |
Some |
1 |
Terazosin (as terazosin hydrochloride) 1 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terazosin hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terazosin hydrochloride |
Inferred relationship |
Some |
1 |
Terazosin (as terazosin hydrochloride) 5 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terazosin hydrochloride |
Inferred relationship |
Some |
1 |
Terazosin (as terazosin hydrochloride) 10 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Terazosin hydrochloride |
Inferred relationship |
Some |
1 |
Terazosin hydrochloride dihydrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Terazosin hydrochloride |
Inferred relationship |
Some |
|
Terazosin hydrochloride anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Terazosin hydrochloride |
Inferred relationship |
Some |
|